Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer

● In Stock

Catalogue No.:VE009372
CAS No.:N/A
Mol. Formula:C24H31ClN2O4
Mol. Weight:447.00 g/mol

Additional information on Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer

Parent drug

Cetirizine

IUPAC Name

1-Hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate compound with 2-hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate (1:1)

Synonyms

N/A

Smiles

O=C(OCC(O)C)COCCN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1

InChI

InChI=1S/C24H31ClN2O4/c1-19(28)17-31-23(29)18-30-16-15-26-11-13-27(14-12-26)24(20-5-3-2-4-6-20)21-7-9-22(25)10-8-21/h2-10,19,24,28H,11-18H2,1H3

Description

Mixture of Propylene Glycol Ester Of Cetrizine Diastereomer standard is a well-characterized compound that aligns with key regulatory guidelines, including USP, EMA, JP, and BP. It plays a crucial role in analytical method development, method validation (AMV), and quality control (QC) processes, particularly in the manufacturing of Cetirizine. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), ensuring reliable and precise analytical outcomes. A mixture of Propylene Glycol Ester Of Cetrizine Diastereomer or 1-Hydroxypropan-2-yl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazine-1-yl)ethoxy)acetate compound with 2-hydroxypropyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazine-1-yl)ethoxy)acetate (1:1), is a selective Histamine-1 antagonist, it is used in the treatment sneezing, coughing, nasal congestion, the active metabolite of the piperazine H1-receptor antagonist hydroxyzine, the volume of distribution: 0.44 and plasma protein binding is 93%.

References

Naqvi, Aasim, and Valerie Gerriets. “Cetirizine.” Nih.gov, StatPearls Publishing, 27 Nov. 2021, www.ncbi.nlm.nih.gov/books/NBK549776/. ‌

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url